Ann Vasc Surg Brief Rep Innov . Recurrent Upper Extremity Arterial Thrombosis Preceding a Diagnosis of COVID-19

[tetano]

Ann Vasc Surg Brief Rep Innov


. 2022 Nov 24;100148.
doi: 10.1016/j.avsurg.2022.100148. Online ahead of print.
Recurrent Upper Extremity Arterial Thrombosis Preceding a Diagnosis of COVID-19


Raymond Kennedy ¹ , Ariel Schneier ² , Mohammed Javed ³ , Huong Truong ¹



Affiliations

• PMID: 36447618
• PMCID: PMC9686053
• DOI: 10.1016/j.avsurg.2022.100148

Abstract

Arterial thrombosis occurs when there is endothelial damage in the setting of hypercoagulability and arterial blood stasis. COVID-19 has been theorized to cause both endothelial damage and promote hypercoagulability by causing an imbalance of clotting factors. In many studies, there have been a large proportion of COVID-19 patients that suffered a thromboembolic event, in both the venous and arterial systems. Our patient, who did not have a significant past medical history, presented with a recurrent brachial artery occlusion despite medical and surgical management, and subsequently tested positive for COVID-19 late in his admission. In conclusion, there is high suspicion that there is a relationship between COVID-19 infection and recurrent arterial thrombosis.

Keywords: COVID-19; SARS-CoV2; anticoagulation; arterial occlusion; coronavirus; thrombosis.